Literature DB >> 1443046

Differential permeability of the blood-brain barrier in experimental brain metastases produced by human neoplasms implanted into nude mice.

R D Zhang1, J E Price, T Fujimaki, C D Bucana, I J Fidler.   

Abstract

This study clarified whether and when the blood-brain barrier in experimental brain metastases is impaired by using hydrosoluble sodium fluorescein (MW 376) as a blood-brain barrier function indicator. Cells from eight human tumor lines (four melanomas, two breast carcinomas, one colon carcinoma, and one renal carcinoma) were inoculated into the internal carotid artery of nude mice. Brain metastases at different stages of development were sampled and the permeability of the blood-brain barrier around the metastases determined. Histologic examination showed two patterns of tumor growth. In the first, tumor cells formed isolated, well-defined nodules in the parenchyma of the brain. In lesions smaller than 0.2 mm2, the blood-brain barrier was intact. In the second, small diffuse nests of tumor cells were distributed throughout the brain parenchyma. The blood-brain barrier was intact until the small tumor cell colonies coalesced to form large tumor masses. These results suggest that the permeability of the blood-brain barrier varies among different experimental brain metastases and that its function is related to the growth pattern and size of the lesions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1443046      PMCID: PMC1886664     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  46 in total

Review 1.  Aluminum-induced neurotoxicity: alterations in membrane function at the blood-brain barrier.

Authors:  W A Banks; A J Kastin
Journal:  Neurosci Biobehav Rev       Date:  1989       Impact factor: 8.989

2.  Morphological changes in acute cerebral ischemia after occlusion and reperfusion in the rat.

Authors:  Y Nakagawa; N Fujimoto; K Matsumoto; J Cervós-Navarro
Journal:  Adv Neurol       Date:  1990

3.  Brain and plasma pharmacokinetics and anticancer activities of cyclophosphamide and phosphoramide mustard in the rat.

Authors:  S Genka; J Deutsch; P L Stahle; U H Shetty; V John; C Robinson; S I Rapoport; N H Greig
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

4.  Angiogenesis and blood-brain barrier breakdown modulate CT contrast enhancement: an experimental study in a rabbit brain-tumor model.

Authors:  D Zagzag; M Goldenberg; S Brem
Journal:  AJR Am J Roentgenol       Date:  1989-07       Impact factor: 3.959

5.  Unique patterns of brain metastasis produced by different human carcinomas in athymic nude mice.

Authors:  G Schackert; J E Price; C D Bucana; I J Fidler
Journal:  Int J Cancer       Date:  1989-11-15       Impact factor: 7.396

6.  The importance of brain temperature in alterations of the blood-brain barrier following cerebral ischemia.

Authors:  W D Dietrich; R Busto; M Halley; I Valdes
Journal:  J Neuropathol Exp Neurol       Date:  1990-09       Impact factor: 3.685

7.  An improved closed cranial window technique for investigation of blood-brain barrier function and cerebral vasomotor control in the rat.

Authors:  S Kawamura; L Schürer; A Goetz; O Kempski; B Schmucker; A Baethmann
Journal:  Int J Microcirc Clin Exp       Date:  1990-11

8.  Blood-brain barrier permeability of human gliomas as determined by quantitation of cytoplasmic vesicles of the capillary endothelium and scintigraphic findings.

Authors:  S Kohn; D Front; I Nir
Journal:  Cancer Invest       Date:  1989       Impact factor: 2.176

9.  Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat.

Authors:  N H Greig; T T Soncrant; H U Shetty; S Momma; Q R Smith; S I Rapoport
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

10.  Regional growth of different human melanomas as metastases in the brain of nude mice.

Authors:  G Schackert; J E Price; R D Zhang; C D Bucana; K Itoh; I J Fidler
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

View more
  64 in total

1.  Differential microstructure and physiology of brain and bone metastases in a rat breast cancer model by diffusion and dynamic contrast enhanced MRI.

Authors:  Matthew D Budde; Eric Gold; E Kay Jordan; Joseph A Frank
Journal:  Clin Exp Metastasis       Date:  2011-11-01       Impact factor: 5.150

Review 2.  Therapeutic approaches for HER2-positive brain metastases: circumventing the blood-brain barrier.

Authors:  Ankit I Mehta; Adam M Brufsky; John H Sampson
Journal:  Cancer Treat Rev       Date:  2012-06-22       Impact factor: 12.111

Review 3.  RNA interference and nonviral targeted gene therapy of experimental brain cancer.

Authors:  Ruben J Boado
Journal:  NeuroRx       Date:  2005-01

Review 4.  Brain metastases: 1995. A brief review.

Authors:  J B Posner
Journal:  J Neurooncol       Date:  1996-03       Impact factor: 4.130

Review 5.  The biology of brain metastases-translation to new therapies.

Authors:  April F Eichler; Euiheon Chung; David P Kodack; Jay S Loeffler; Dai Fukumura; Rakesh K Jain
Journal:  Nat Rev Clin Oncol       Date:  2011-04-12       Impact factor: 66.675

6.  MRI evaluation of the effects of whole brain radiotherapy on breast cancer brain metastasis.

Authors:  William Crowe; Lulu Wang; Zhongwei Zhang; Jasmina Varagic; J Daniel Bourland; Michael D Chan; Amyn A Habib; Dawen Zhao
Journal:  Int J Radiat Biol       Date:  2019-01-07       Impact factor: 2.694

7.  Clinically significant CMV (re)activation during or after radiotherapy/chemotherapy of the brain : Correlation with neurological deterioration and improvement upon antiviral treatment.

Authors:  N Goerig; S Semrau; B Frey; K Korn; B Fleckenstein; K Überla; A Dörfler; F Putz; U S Gaipl; R Fietkau
Journal:  Strahlenther Onkol       Date:  2016-05-31       Impact factor: 3.621

8.  Ultrasound imaging-guided intracardiac injection to develop a mouse model of breast cancer brain metastases followed by longitudinal MRI.

Authors:  Heling Zhou; Dawen Zhao
Journal:  J Vis Exp       Date:  2014-03-06       Impact factor: 1.355

9.  Cytokine immuno-gene therapy for treatment of brain tumors.

Authors:  Terry Lichtor; Roberta P Glick
Journal:  J Neurooncol       Date:  2003-12       Impact factor: 4.130

10.  Isolated cerebral susceptibility artefacts in patients with malignant melanoma: metastasis or not?

Authors:  Carolin Gramsch; Sophia L Göricke; Felix Behrens; Lisa Zimmer; Dirk Schadendorf; Andrej Krasny; Michael Forsting; Marc U Schlamann
Journal:  Eur Radiol       Date:  2013-05-14       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.